Equity
₹4.6CrUp to
SOSV Deep Tech Accelerator Program (SOSV SF & SOSV NY)
by SOSV
SOSV invests in pre-seed deep tech startups focused on human & planetary health, offering labs, mentorship, and investor network.
Rolling
ViewSOSV
SOSV is an accelerator with 1 startup funding programme on startupfunds. Browse every opportunity below, with eligibility, amounts and how to apply.
1 program1 open nowUpdated regularly
Quick answer
SOSV runs 1 startup funding program listed on startupfunds, spanning equity funding up to ₹4.6Cr. 1 is accepting applications right now.
- Programs listed
- 1 (1 open now)
- Funding types
- Equity
- Funding amount
- Up to ₹4.6Cr
- Provider type
- Accelerator
- Geography
- India & international founders
About SOSV
Global deep science VC running world-class accelerators including HAX, IndieBio, and Food-X.
What SOSV funds
Filters that match SOSV's programs — tap one to see every grant in that category.
Active programs from SOSV
Frequently asked questions
What founders ask about funding from SOSV.
How many funding programs does SOSV offer?
SOSV currently lists 1 startup funding program on startupfunds, of which 1 is open to applications right now. New cohorts are added as SOSV announces them.
What type of funding does SOSV provide?
SOSV backs startups through equity funding. Funding is typically up to ₹4.6Cr.
How much funding can a startup get from SOSV?
SOSV's programs offer up to ₹4.6Cr. The exact amount depends on the specific program, stage and your startup's needs.
Who is eligible for SOSV funding?
SOSV's programs are open to founders in India and worldwide. Each program lists its own eligibility — check the one you're interested in below.
How do I apply to SOSV programs?
Pick the SOSV program you're interested in from the list below to see its eligibility, funding amount, deadline and step-by-step how-to-apply guide. Applications are submitted through SOSV's official channels; you can also reach their official site from the top of this page.
Browse more startup funding
Compare SOSV's programs against the wider funding landscape.